Spots Global Cancer Trial Database for ac [adriamycin (a) (also known as doxorubicin) and cyclophosphamide (c)] followed by paclitaxel (p)
Every month we try and update this database with for ac [adriamycin (a) (also known as doxorubicin) and cyclophosphamide (c)] followed by paclitaxel (p) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility | NCT00591851 | Breast Cancer | AC [Adriamycin ... | 18 Years - | Memorial Sloan Kettering Cancer Center |